Graphic: corner
spacer
Graphic: corner
spacer spacer
nav left edge
nav right edge
spacer

News Release Mars Petcare Acquires OptiGen, LLC

April 10, 2018

OptiGen and Mars Petcare's genetic testing unit, Wisdom Health are pleased to announce exciting news…  For many years, both OptiGen and Mars Petcare have enjoyed an informal relationship of cross marketing and collaboration on research projects. Now we are formally joining forces through Mars’ acquisition of OptiGen. Our companies’ mutual commitments to provide the highest quality of DNA testing services for dogs, supporting research aimed at identifying causes of inherited diseases, as well as our shared respect for intellectual property where it exists in the field, makes this an excellent fit. Through this evolution, we believe our clients will greatly benefit from access to an expanded array of multiple tests—both for inherited diseases of particular interest to their breed,  as well as to tests for physical traits such as coat color and body size that have not previously been offered by OptiGen.

To all of OptiGen’s loyal customers, we want to assure you that we are confident that Wisdom  Health shares the same absolute commitment to providing accurate and timely test results as you have come to expect from OptiGen. During the transition, all members of the OptiGen team will remain at our Ithaca location and we look forward to assisting you, as always. Some aspects of the long term operations are yet to be determined as we configure the best way to serve our customers but in the immediate phase, please continue to order and send samples to OptiGen via our website just as you have always done.

Although there are still questions about long-term operations following the acquisition, there are some important certainties that will remain:
  • Utmost commitment to accuracy and customer service.
  •  Expert genetic counseling and guidance for how to best use the DNA tests for your breeding program. Clients who make use of this service will benefit from additional veterinary expertise provided by Wisdom Health.
  •  Acceptance by the OFA and all other breed or health registries of all test results.
  •  Archived samples, i.e. samples that you have previously sent to OptiGen for testing, will still be available with the option of adding new tests as they are developed. 
  •  Access to your dog’s testing data, including copies of test reports, for dogs you have previously submitted to OptiGen, will remain available.
  • Continued investment in research projects and our commitment to identifying new mutations that cause serious inherited diseases in dogs.

As technology in the field of canine genetic testing has continued to advance, OptiGen has been searching for how to make the best leap to new platforms. With Wisdom Health as a leader in this field, we believe they are by far our best partner to make this transition, and with them we look forward to providing our clients with state-of-the-art DNA testing services while at the same time lowering overall costs. To help you become familiar with the new expanded services that will be phased in following the acquisition, please visit the webpage for Optimal Selection (in North America) or MyDogDNA (for countries outside of North America). For a quick view of the breed-specific tests for canine inherited diseases offered by these panel tests, please use the search engine available on the “Breeds” section of MyDogDNA.com’s website.

All of us on the OptiGen team are excited about this new chapter in our 20 year history of serving conscientious dog breeders around the world. We hope and expect this new alliance will provide you with even greater opportunities to produce the highest quality dogs in your breeding program. We remain thankful to our many friends in the field who have supported OptiGen over the years and we look forward to continuing to provide you with the best possible services available in canine genetic testing.


spacer
Graphic: footer bar left
OptiGen®, LLC · Cornell Business & Technology Park · 767 Warren Road, Suite 300 · Ithaca, New York 14850
Tel: 607 257 0301 · Fax: 607 257 0353 · email: genetest@optigen.com or optigen@clarityconnect.com
Graphic: footer bar right
spacer spacer
spacer
spacer
spacer